4833X 15/1000 (Actoplus met XR 1000 mg / 15 mg)

Generic Name: metformin/pioglitazone

Pill imprint 4833X 15/1000 has been identified as Actoplus met XR 1000 mg / 15 mg.

ActoPlus Met XR is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. ActoPlus Met XR 1000 mg / 15 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 4833X 15/1000

Actoplus met XR 1000 mg / 15 mg 4833X 15/1000
Actoplus met XR 1000 mg / 15 mg 4833X 15/1000
Actoplus met XR
Generic Name:
metformin/pioglitazone
Imprint:
4833X 15/1000
Strength:
1000 mg / 15 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Takeda Pharmaceuticals America
National Drug Code (NDC):
64764-0510
Inactive Ingredients:
candelilla wax
cellulose acetate
povidone
hydroxypropyl cellulose (type h)
lactose monohydrate
magnesium stearate
hypromelloses
polyethylene glycol 400
polyethylene glycol 8000
sodium lauryl sulfate
titanium dioxide
triacetin
shellac
propylene glycol
ammonia
ferric oxide red

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)